While Habal et al. found no significant differences in IL-6 or TNF-α levels between patients with CU/angioedema and controls, other studies have demonstrated clinical efficacy of TNF-α inhibitors in CU patients [42,43,44]. The gene discussed is IL6; the disease is angioedema.